A microbiome-bile acid axis mediates protection from chronic liver disease in females
IsoUDCA, a female-enriched bile acid produced by a gut bacterial consortium favored by estrogen, promotes hepatic cholesterol handling and bile acid metabolism through SREBP2-STARD4-CYP7B1 signaling, thereby alleviating chronic liver injury.
